Try our mobile app

Sangamo Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Conference

Published: 2020-08-10 12:30:00 ET
<<<  go to SGMO company page

BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Sandy Macrae, CEO of Sangamo, will present at the 2020 Wedbush PacGrow Healthcare Conference on August 12, 2020 at 2:55 p.m. Eastern Time.

The presentation will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com.

Investor Relations – Global McDavid Stilwell 510-970-6000, x219 mstilwell@sangamo.com Media Inquiries – Global Aron Feingold 510-970-6000, x421 afeingold@sangamo.com

Source: Sangamo Therapeutics, Inc.